HLB Co., Ltd.
028300
Rank in Stocks
#4138
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Share Price
$29.28
Market Cap
$3.89B
Change (1 day)
-1.40%
Change (1 year)
-8.45%
Country
KR
Trade HLB Co., Ltd. (028300)
Category
Healthcare
Revenue for HLB Co., Ltd. (028300)
Revenue in Jun 2026 TTM: $67.40M
According to HLB Co., Ltd. latest financial reports the company's current revenue (TTM) is $67.40M. In 2023 the company made a revenue of $33.14M a decrease compared to the revenue in the year 2022 that was $142.41M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for HLB Co., Ltd. from 2012 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $67.40M | 45.45% |
| 2024 | $46.34M | 39.83% |
| 2023 | $33.14M | -76.73% |
| 2022 | $142.41M | 142.47% |
| 2021 | $58.73M | 13.50% |
| 2020 | $51.75M | 55.52% |
| 2019 | $33.27M | 2.38% |
| 2018 | $32.50M | 50.54% |
| 2017 | $21.59M | -13.64% |
| 2016 | $25.00M | -23.62% |
| 2015 | $32.73M | -3.69% |
| 2014 | $33.98M | 71.94% |
| 2013 | $19.76M | -59.26% |
| 2012 | $48.51M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $12.62B | 18,631.01% |
US
|
|
| $2.23B | 3,205.74% |
US
|
|
| $15.74B | 23,260.28% |
AU
|
|
| $6.02B | 8,833.94% |
NL
|
|
| - | - |
CH
|
